John David Hansen, PRESIDENT AND CEO at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), bought 4,286 shares at $1.75 ($8K) on 2017-05-19, disclosed to the SEC on 2017-08-02.
Open-market purchase of $8k MBVX by PRESIDENT AND CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| MBVX | SELL | 2017-04-14 | $20K | — | Filing → |
| MBVX | SELL | 2017-04-11 | $3K | — | Filing → |
| MBVX | SELL | 2017-04-06 | $11K | — | Filing → |